{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:40:22Z","timestamp":1792518022259,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2023-149538NB-I00"],"award-info":[{"award-number":["PID2023-149538NB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["FPU19\/04914"],"award-info":[{"award-number":["FPU19\/04914"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["RED2022-134927-T"],"award-info":[{"award-number":["RED2022-134927-T"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00315"],"award-info":[{"award-number":["PI23\/00315"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD23\/00104"],"award-info":[{"award-number":["CD23\/00104"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014139","name":"CIBERONC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"State Agency of Research","doi-asserted-by":"publisher","award":["PID2021-124251OB-I00"],"award-info":[{"award-number":["PID2021-124251OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"State Agency of Research","doi-asserted-by":"publisher","award":["PID2024-156338OB-I00"],"award-info":[{"award-number":["PID2024-156338OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"State Agency of Research","doi-asserted-by":"publisher","award":["PID2023-149538NB-I00"],"award-info":[{"award-number":["PID2023-149538NB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"State Agency of Research","doi-asserted-by":"publisher","award":["PID2022-136854OB-I00"],"award-info":[{"award-number":["PID2022-136854OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CB16\/12\/00295"],"award-info":[{"award-number":["CB16\/12\/00295"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A29754"],"award-info":[{"award-number":["A29754"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.canlet.2026.218565","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:00:48Z","timestamp":1777932048000},"page":"218565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["FGFR1 drives metabolic adaptation associated with temozolomide resistance in glioblastoma"],"prefix":"10.1016","volume":"652","author":[{"given":"Laura","family":"Zarzuela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio G.","family":"L\u00f3pez-Cepero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0212-0017","authenticated-orcid":false,"given":"Kevin M.","family":"Rattigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Reina-Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mart\u00edn-Montalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas M.","family":"Sierra-P\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"S\u00e1nchez-Escabias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Morillo-Huesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S.","family":"Oltra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Ceballos-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2020-1662","authenticated-orcid":false,"given":"Vivian","family":"Capilla-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Moreno-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5703-352X","authenticated-orcid":false,"given":"Piedad del Socorro","family":"Murdoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Vignir","family":"Helgason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8682-1800","authenticated-orcid":false,"given":"Mercedes","family":"Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2249-9215","authenticated-orcid":false,"given":"Ra\u00fal V.","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218565_bib1","first-page":"iii1","article-title":"CBTRUS statistical report: american brain tumor association & NCI neuro-oncology branch adolescent and young adult primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020, neuro","volume":"26","author":"Price","year":"2024","journal-title":"Oncol"},{"key":"10.1016\/j.canlet.2026.218565_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218565_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218565_bib4","first-page":"421","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma\u2014A critical review","volume":"2","author":"Komotar","year":"2008","journal-title":"Clin. Med. Oncol."},{"key":"10.1016\/j.canlet.2026.218565_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-008-9538-0","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients","volume":"88","author":"Minniti","year":"2008","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218565_bib6","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1158\/0008-5472.CAN-13-1384","article-title":"Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53","volume":"73","author":"Licciulli","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218565_bib7","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1158\/1078-0432.CCR-24-0426","article-title":"Bystander effects, pharmacokinetics, and linker-payload stability of EGFR-Targeting antibody-drug conjugates Losatuxizumab Vedotin and Depatux-M in glioblastoma models","volume":"30","author":"Jain","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218565_bib8","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.ijrobp.2019.06.539","article-title":"Randomized phase II trial of Re-Irradiation and concurrent bevacizumab versus bevacizumab alone as treatment for recurrent glioblastoma (NRG Oncology\/RTOG 1205): initial outcomes and RT plan quality report","volume":"105","author":"Tsien","year":"2019","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.canlet.2026.218565_bib9","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1158\/1078-0432.CCR-07-1719","article-title":"Mechanisms of chemoresistance to alkylating agents in malignant glioma","volume":"14","author":"Sarkaria","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218565_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.canlet.2026.218565_bib11","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.1021\/bi00197a003","article-title":"NMR and molecular modeling investigation of the mechanism of activation of the Antitumor Drug temozolomide and its interaction with DNA","volume":"33","author":"Denny","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.canlet.2026.218565_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218565_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0305-7372(97)90019-0","article-title":"Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials","volume":"23","author":"Newlands","year":"1997","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2026.218565_bib14","first-page":"1","article-title":"Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance","author":"Zarzuela","year":"2023","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2026.218565_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.202101736R","article-title":"A positive feedback circuit comprising p21 and HIF-1\u03b1 aggravates hypoxia-induced radioresistance of glioblastoma by promoting Glut1\/LDHA-mediated glycolysis","volume":"36","author":"Jin","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2026.218565_bib16","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.celrep.2019.07.002","article-title":"Glutamine synthetase promotes radiation resistance via facilitating nucleotide metabolism and subsequent DNA damage repair","volume":"28","author":"Fu","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218565_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.201798772","article-title":"Infiltrative and drug\u2010resistant slow\u2010cycling cells support metabolic heterogeneity in glioblastoma","volume":"37","author":"Hoang\u2010Minh","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2026.218565_bib18","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1016\/j.celrep.2020.02.014","article-title":"Glioblastoma cell resistance to EGFR and MET inhibition can be overcome via blockade of FGFR-SPRY2 bypass signaling","volume":"30","author":"Day","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218565_bib19","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.1211962109","article-title":"Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240","volume":"109","author":"Fenton","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218565_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101390","article-title":"Constitutive activation of Notch2 signalling confers chemoresistance to neural stem cells via transactivation of fibroblast growth factor receptor-1","volume":"35","author":"Tom\u00e9","year":"2019","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.canlet.2026.218565_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2014.04.010","article-title":"Kinomic exploration of temozolomide and radiation resistance in glioblastoma multiforme xenolines","volume":"111","author":"Anderson","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218565_bib22","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1158\/0008-5472.CAN-15-2058","article-title":"FGFR1 induces glioblastoma radioresistance through the PLCg\/Hif1a pathway","volume":"76","author":"Gouaz\u00e9-Andersson","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218565_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells14181427","article-title":"FGFR1 inhibition by pemigatinib enhances radiosensitivity in glioblastoma stem cells through S100A4 downregulation","volume":"14","author":"Gouaz\u00e9-Andersson","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218565_bib24","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-18-1308","article-title":"ADAMDEC1 maintains a growth factor signaling loop in cancer stem cells","volume":"9","author":"Jimenez-Pascual","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218565_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030406","article-title":"Alpha6-integrin regulates FGFR1 expression through the ZEB1\/YAP1 transcription complex in glioblastoma stem cells resulting in enhanced proliferation and stemness","volume":"11","author":"Kowalski-Chauvel","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218565_bib26","first-page":"1957","article-title":"p53 effects both the duration of G2\/M arrest and the fate of temozolomide-treated human glioblastoma cells","volume":"61","author":"Hirose","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218565_bib27","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2015.3255","article-title":"P53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis","volume":"11","author":"Miao","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2026.218565_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3236","article-title":"Reductive glutamine metabolism is a function of the \u03b1-ketoglutarate to citrate ratio in cells","volume":"4","author":"Fendt","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218565_bib29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218565_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI38942","article-title":"Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction","volume":"120","author":"Samudio","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218565_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrc3162","article-title":"Choline metabolism in malignant transformation","volume":"11","author":"Glunde","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218565_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.canlet.2026.218565_bib33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218565_bib34","doi-asserted-by":"crossref","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218565_bib35","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.freeradbiomed.2018.04.397","article-title":"Insight the mechanism of ferroptosis inhibition by ferrostatin-1","volume":"120","author":"Miotto","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.canlet.2026.218565_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218565_bib37","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1111\/jcmm.15133","article-title":"MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1\/PI3K\/AKT pathway","volume":"24","author":"Kong","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2026.218565_bib38","article-title":"Elucidating the mechanisms of temozolomide resistance in gliomas and the strategies to overcome the resistance","volume":"1876","author":"Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2026.218565_bib39","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.1220834","article-title":"Transforming fusions of FGFR and TACC genes in human glioblastoma","volume":"337","author":"Singh","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218565_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218565_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2015.08.026","article-title":"The human glioblastoma cell culture resource: validated cell models representing all molecular subtypes","volume":"2","author":"Xie","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2026.218565_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.2910550618","article-title":"p53 protein accumulation and gene mutations in human glioma cell lines","volume":"55","author":"Anker","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218565_bib43","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2026.218565_bib44","series-title":"Rsamtools: Binary Alignment (BAM), FASTA, Variant Call (BCF), and Tabix File Import","author":"Morgan M","year":"2025"},{"key":"10.1016\/j.canlet.2026.218565_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2026.218565_bib46","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218565_bib47","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2026.218565_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41589-022-01154-9","article-title":"Hepatic glutamine synthetase controls N 5-methylglutamine in homeostasis and cancer","volume":"19","author":"Villar","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218565_bib49","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.7150\/thno.104143","article-title":"Glioblastoma progression is hindered by melatonin-primed mesenchymal stromal cells through dynamic intracellular and extracellular reorganizations","volume":"15","author":"Olmedo-Moreno","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218565_bib50","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:00:59Z","timestamp":1792515659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526003289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S0304383526003289"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218565","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGFR1 drives metabolic adaptation associated with temozolomide resistance in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218565"}}